Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $6,126 | 181 | 91.3% |
| Travel and Lodging | $583.39 | 9 | 8.7% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Nevro Corp. | $2,615 | 58 | $0 (2024) |
| Boston Scientific Corporation | $1,552 | 16 | $0 (2023) |
| Medtronic, Inc. | $582.93 | 7 | $0 (2023) |
| Abbott Laboratories | $329.21 | 15 | $0 (2022) |
| Medtronic USA, Inc. | $310.59 | 5 | $0 (2019) |
| Daiichi Sankyo Inc. | $246.55 | 28 | $0 (2019) |
| PFIZER INC. | $188.85 | 24 | $0 (2018) |
| Allergan, Inc. | $162.22 | 2 | $0 (2020) |
| Averitas Pharma Inc. | $152.97 | 1 | $0 (2024) |
| Amgen Inc. | $133.29 | 6 | $0 (2020) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $933.59 | 14 | Nevro Corp. ($759.03) |
| 2023 | $1,061 | 14 | Medtronic, Inc. ($570.20) |
| 2022 | $373.13 | 7 | Nevro Corp. ($316.24) |
| 2021 | $685.06 | 17 | Nevro Corp. ($623.96) |
| 2020 | $457.55 | 22 | Nevro Corp. ($330.95) |
| 2019 | $1,022 | 27 | Boston Scientific Corporation ($410.54) |
| 2018 | $625.06 | 46 | Abbott Laboratories ($242.78) |
| 2017 | $1,553 | 43 | BOSTON SCIENTIFIC CORPORATION ($1,124) |
All Payment Transactions
190 individual payment records from CMS Open Payments — Page 1 of 8
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 09/14/2024 | Nevro Corp. | Senza (Device) | Food and Beverage | In-kind items and services | $116.11 | General |
| Category: Spinal Cord Stimulator | ||||||
| 08/22/2024 | Nevro Corp. | Senza (Device) | Food and Beverage | In-kind items and services | $117.10 | General |
| Category: Spinal Cord Stimulator | ||||||
| 07/24/2024 | Nevro Corp. | Senza (Device) | Food and Beverage | In-kind items and services | $52.87 | General |
| Category: Spinal Cord Stimulator | ||||||
| 07/09/2024 | Nalu Medical, Inc. | Nalu Neurostimulation System (Device) | Food and Beverage | In-kind items and services | $21.59 | General |
| Category: Pain Management | ||||||
| 05/23/2024 | Nevro Corp. | Senza (Device) | Food and Beverage | In-kind items and services | $79.50 | General |
| Category: Spinal Cord Stimulator | ||||||
| 05/09/2024 | Nevro Corp. | Senza (Device) | Food and Beverage | In-kind items and services | $23.76 | General |
| Category: Spinal Cord Stimulator | ||||||
| 05/08/2024 | Averitas Pharma Inc. | QUTENZA (Drug) | Food and Beverage | In-kind items and services | $152.97 | General |
| Category: PAIN MANAGEMENT | ||||||
| 05/06/2024 | Nevro Corp. | Senza (Device) | Travel and Lodging | In-kind items and services | $5.76 | General |
| Category: Spinal Cord Stimulator | ||||||
| 05/05/2024 | Nevro Corp. | Senza (Device) | Travel and Lodging | In-kind items and services | $31.88 | General |
| Category: Spinal Cord Stimulator | ||||||
| 05/04/2024 | Nevro Corp. | Senza (Device) | Travel and Lodging | In-kind items and services | $75.48 | General |
| Category: Spinal Cord Stimulator | ||||||
| 05/03/2024 | Nevro Corp. | Senza (Device) | Travel and Lodging | In-kind items and services | $0.16 | General |
| Category: Spinal Cord Stimulator | ||||||
| 03/13/2024 | Nevro Corp. | Senza (Device) | Food and Beverage | In-kind items and services | $128.97 | General |
| Category: Spinal Cord Stimulator | ||||||
| 02/16/2024 | Nevro Corp. | Senza (Device) | Food and Beverage | In-kind items and services | $105.15 | General |
| Category: Spinal Cord Stimulator | ||||||
| 01/09/2024 | Nevro Corp. | Senza (Device) | Food and Beverage | In-kind items and services | $22.29 | General |
| Category: Spinal Cord Stimulator | ||||||
| 10/24/2023 | Nevro Corp. | Senza (Device) | Food and Beverage | In-kind items and services | $29.18 | General |
| Category: Spinal Cord Stimulator | ||||||
| 10/09/2023 | Medtronic, Inc. | KYPHON EXPRESS II KYPHOPAK TRAY (Device) | Food and Beverage | In-kind items and services | $39.48 | General |
| Category: Neuro Pain (includes Interventional) | ||||||
| 10/07/2023 | Medtronic, Inc. | KYPHON EXPRESS II KYPHOPAK TRAY (Device) | Food and Beverage | In-kind items and services | $66.42 | General |
| Category: Neuro Pain (includes Interventional) | ||||||
| 10/07/2023 | Medtronic, Inc. | KYPHON EXPRESS II KYPHOPAK TRAY (Device) | Travel and Lodging | In-kind items and services | $45.80 | General |
| Category: Neuro Pain (includes Interventional) | ||||||
| 10/07/2023 | Medtronic, Inc. | KYPHON EXPRESS II KYPHOPAK TRAY (Device) | Travel and Lodging | In-kind items and services | $40.98 | General |
| Category: Neuro Pain (includes Interventional) | ||||||
| 09/21/2023 | Nevro Corp. | Senza (Device) | Food and Beverage | In-kind items and services | $88.75 | General |
| Category: Spinal Cord Stimulator | ||||||
| 09/12/2023 | Medtronic, Inc. | KYPHON EXPRESS II KYPHOPAK TRAY (Device) | Travel and Lodging | In-kind items and services | $345.21 | General |
| Category: Neuro Pain (includes Interventional) | ||||||
| 09/12/2023 | Medtronic, Inc. | KYPHON EXPRESS II KYPHOPAK TRAY (Device) | Travel and Lodging | In-kind items and services | $32.31 | General |
| Category: Neuro Pain (includes Interventional) | ||||||
| 06/01/2023 | Nevro Corp. | Senza (Device) | Food and Beverage | In-kind items and services | $7.37 | General |
| Category: Spinal Cord Stimulator | ||||||
| 01/14/2023 | Boston Scientific Corporation | WaveWriter Alpha Prime 16 (Device) | Food and Beverage | In-kind items and services | $17.14 | General |
| Category: WaveWriter Alpha_NMD | ||||||
| 01/13/2023 | Nevro Corp. | Senza (Device) | Food and Beverage | In-kind items and services | $174.16 | General |
| Category: Spinal Cord Stimulator | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 26 | 1,981 | 5,412 | $1.6M | $258,448 |
| 2022 | 28 | 1,579 | 4,742 | $1.0M | $189,658 |
| 2021 | 28 | 1,788 | 5,139 | $706,237 | $221,059 |
| 2020 | 28 | 1,818 | 3,855 | $444,307 | $148,581 |
All Medicare Procedures & Services
112 procedure records from CMS Medicare Utilization — Page 1 of 5
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 318 | 1,135 | $486,915 | $66,736 | 13.7% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 217 | 519 | $315,033 | $45,005 | 14.3% |
| 64635 | Destruction of lower or sacral spinal facet joint nerves using imaging guidance, single facet joint | Office | 2023 | 52 | 58 | $120,930 | $27,153 | 22.5% |
| 80307 | Testing for presence of drug, by chemistry analyzers | Office | 2023 | 181 | 306 | $94,554 | $18,581 | 19.7% |
| 64636 | Destruction of lower or sacral spinal facet joint nerves using imaging guidance, each additional facet joint | Office | 2023 | 52 | 58 | $66,120 | $14,797 | 22.4% |
| 99490 | Chronic care management services, first 20 minutes of clinical staff time directed by health care professional, per calendar month | Office | 2023 | 106 | 277 | $96,950 | $12,820 | 13.2% |
| 64493 | Injection of lower or sacral spine facet joint using imaging guidance, single level | Office | 2023 | 40 | 63 | $51,534 | $11,506 | 22.3% |
| 77002 | Fluoroscopic guidance for needle placement | Office | 2023 | 45 | 89 | $47,793 | $7,181 | 15.0% |
| 80305 | Testing for presence of drug, read by direct observation | Office | 2023 | 204 | 564 | $28,200 | $6,965 | 24.7% |
| 62323 | Injection of substance into lower spine canal using imaging guidance | Office | 2023 | 33 | 40 | $48,560 | $6,611 | 13.6% |
| 64494 | Injection of lower or sacral spine facet joint using imaging guidance, second level | Office | 2023 | 40 | 63 | $26,964 | $6,203 | 23.0% |
| 99442 | Telephone medical discussion with physician, 11-20 minutes | Office | 2023 | 106 | 160 | $68,320 | $5,941 | 8.7% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 53 | 53 | $42,082 | $5,656 | 13.4% |
| 64483 | Injection of anesthetic and/or steroid drug into sacral spine nerve root using imaging guidance, single level | Office | 2023 | 21 | 24 | $27,840 | $4,693 | 16.9% |
| 20610 | Aspiration and/or injection of fluid from large joint | Office | 2023 | 38 | 77 | $23,562 | $4,437 | 18.8% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2023 | 57 | 57 | $30,210 | $4,215 | 14.0% |
| 27096 | Injection of anesthetic or steroid into joint between lower spine and hip bone using imaging guidance | Office | 2023 | 21 | 29 | $22,098 | $3,809 | 17.2% |
| 99152 | Use of a drug to induce depression of consciousness by physician performing a procedure (5 years or older), initial 15 minutes | Office | 2023 | 38 | 52 | $5,200 | $1,853 | 35.6% |
| 20553 | Injection of trigger points, 3 or more muscles | Office | 2023 | 35 | 45 | $13,095 | $1,750 | 13.4% |
| 76942 | Ultrasonic guidance for needle placement | Office | 2023 | 13 | 22 | $6,006 | $894.81 | 14.9% |
| J3301 | Injection, triamcinolone acetonide, not otherwise specified, 10 mg | Office | 2023 | 99 | 849 | $8,490 | $679.01 | 8.0% |
| 99439 | Chronic care management services for two or more chronic conditions, additional 20 minutes of clinical staff time directed by health care professional, per calendar month | Office | 2023 | 13 | 14 | $2,100 | $487.62 | 23.2% |
| 99211 | Office or other outpatient visit for the evaluation and management of established patient that may not require presence of healthcare professional | Office | 2023 | 14 | 14 | $1,484 | $199.32 | 13.4% |
| 96127 | Assessment of emotional or behavioral problems | Office | 2023 | 91 | 95 | $4,750 | $174.96 | 3.7% |
| J1100 | Injection, dexamethasone sodium phosphate, 1 mg | Office | 2023 | 51 | 640 | $4,480 | $62.41 | 1.4% |
About Dr. Thomas Whealton, DO
Dr. Thomas Whealton, DO is a Pain Medicine healthcare provider based in Corbin, Kentucky. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 04/12/2012. The National Provider Identifier (NPI) number assigned to this provider is 1811254105.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Thomas Whealton, DO has received a total of $6,709 in payments from pharmaceutical and medical device companies, with $933.59 received in 2024. These payments were reported across 190 transactions from 23 companies. The most common payment nature is "Food and Beverage" ($6,126).
As a Medicare-enrolled provider, Whealton has provided services to 7,166 Medicare beneficiaries, totaling 19,148 services with total Medicare billing of $817,747. Data is available for 4 years (2020–2023), covering 112 distinct procedure/service records.
Practice Information
- Specialty Pain Medicine
- Other Specialties Pain Medicine
- Location Corbin, KY
- Active Since 04/12/2012
- Last Updated 09/06/2024
- Taxonomy Code 207LP2900X
- Entity Type Individual
- NPI Number 1811254105
Products in Payments
- Senza (Device) $1,232
- Omnia (Device) $940.20
- KYPHON EXPRESS II KYPHOPAK TRAY (Device) $570.20
- GENERAL - PAIN MANAGEMENT (Device) $567.39
- SPECTRA SYSTEM (Device) $557.00
- Senza Spinal Cord Stimulation System (Device) $442.04
- SPECTRA WAVEWRITER (Device) $410.54
- LYRICA (Drug) $188.85
- Movantik (Drug) $159.40
- ADAPTIVESTIM (Device) $159.10
- QUTENZA (Drug) $152.97
- BOTOX CHRONIC MIGRAINE (Drug) $147.55
- SYNCHROMED (Device) $129.38
- Zilretta (Drug) $110.08
- Aimovig (Biological) $96.51
- Morphabond ER (Drug) $87.15
- Neuromodulation Dspsbls and Accs (Device) $79.33
- DRG leads (Device) $55.28
- DRG IPGs (Device) $54.17
- Prodigy Family of SCS IPGs (Device) $44.31
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.